sangamo therapeutics ceo: alzheimer's and parkinson's gene therapies | mad money | cnbc
Published 4 years ago • 1.2K plays • Length 6:26Download video MP4
Download video MP3
Similar videos
-
6:56
sangamo therapeutics ceo on partnering with biogen to develop gene-regulation therapies for alzheime
-
8:20
sangamo biosciences ceo edward lanphier | mad money | cnbc
-
6:08
cellectis ceo: creating a cancer fighting machine | mad money | cnbc
-
6:35
prothena corporation ceo: biotech breakthrough | mad money | cnbc
-
7:02
sage therapeutics ceo: challenging conventional wisdom | mad money | cnbc
-
5:38
parkinson’s disease symptoms causes and treatment
-
16:05
how an otc supplement may prevent & slow alzheimer's & parkinson's disease | dr thomas guttuso ep 1
-
6:04
what is the prognosis in parkinson's disease ?
-
6:39
halozyme therapeutics ceo: a step forward | mad money | cnbc
-
2:33
sage therapeutics ceo: mental health is integral to returning to work
-
6:39
halozyme therapeutics ceo dr. helen torley | mad money | cnbc
-
3:45
cramer: biogen's alzheimer's treatment would be 'the biggest drug ever'
-
1:48
parkinson's disease: the struggle is real | you need to know this about parkinson’s disease
-
1:01
sangamo and biogen's gene regulation therapy to fight alzheimer's
-
6:58
bausch health ceo: drug pricing relief | mad money | cnbc
-
16:58
sangamo therapeutics
-
5:46
bausch health companies ceo: stronger position | mad money | cnbc
-
5:39
gene therapy, parkinson's disease, and food science: bayer u.s. discusses the latest technology
-
1:32
study shows reprogrammed cells helped treat parkinson's patient
-
7:47
bausch health companies ceo: pivoting to offense | mad money | cnbc
-
14:35
sangamo therapeutics
-
7:09
parkinson's - movement is medicine | dw english